| Avalo Therapeutics (NASDAQ:AVTX) is now covered by Leerink Partners. They set an "outperform" rating and a $38.00 price target on the stock. This represents a 89.5% upside from the current price of $20.05. |
| ERock (NYSE:EROC) is now covered by Morgan Stanley. They set an "overweight" rating and a $21.00 price target on the stock. This represents a 33.2% upside from the current price of $15.76. |
| ERock (NYSE:EROC) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $24.00 price target on the stock. This represents a 52.3% upside from the current price of $15.76. |
| ERock (NYSE:EROC) is now covered by Wolfe Research. They set an "outperform" rating and a $24.00 price target on the stock. This represents a 52.3% upside from the current price of $15.76. |
| ERock (NYSE:EROC) is now covered by Bank of America Corporation. They set a "neutral" rating and a $16.00 price target on the stock. This represents a 1.5% upside from the current price of $15.76. |
| ERock (NYSE:EROC) is now covered by Guggenheim. They set a "buy" rating and a $23.00 price target on the stock. This represents a 45.9% upside from the current price of $15.76. |
| ERock (NYSE:EROC) is now covered by Barclays PLC. They set an "overweight" rating and a $23.00 price target on the stock. This represents a 45.9% upside from the current price of $15.76. |
| Forbright (NASDAQ:FRBT) is now covered by TD Cowen. They set a "buy" rating on the stock. The current price is $19.01. |
| Forbright (NASDAQ:FRBT) is now covered by Barclays PLC. They set an "overweight" rating and a $23.00 price target on the stock. This represents a 21.0% upside from the current price of $19.01. |
| Forbright (NASDAQ:FRBT) is now covered by JPMorgan Chase & Co.. They set a "neutral" rating and a $21.00 price target on the stock. This represents a 10.5% upside from the current price of $19.01. |
| NRG Energy (NYSE:NRG) is now covered by Siebert Williams Shank. They set a "buy" rating and a $184.00 price target on the stock. This represents a 31.9% upside from the current price of $139.51. |
| Parabilis Medicines (NASDAQ:PBLS) is now covered by Evercore Inc. They set an "outperform" rating on the stock. The current price is $29.68. |
| Parabilis Medicines (NASDAQ:PBLS) is now covered by Leerink Partners. They set an "outperform" rating and a $40.00 price target on the stock. This represents a 34.8% upside from the current price of $29.68. |
| Parabilis Medicines (NASDAQ:PBLS) is now covered by Bank of America Corporation. They set a "buy" rating and a $45.00 price target on the stock. This represents a 51.6% upside from the current price of $29.68. |
| Solaris Energy Infrastructure (NYSE:SEI) is now covered by Wolfe Research. They set an "outperform" rating and a $120.00 price target on the stock. This represents a 73.3% upside from the current price of $69.23. |
| Oncology Institute (NASDAQ:TOI) is now covered by Lake Street Capital. They set a "buy" rating and a $10.00 price target on the stock. This represents a 79.1% upside from the current price of $5.59. |
| WhiteHawk Income (NYSE:WHK) is now covered by Stephens. They set an "overweight" rating and a $33.00 price target on the stock. This represents a 22.1% upside from the current price of $27.02. |
| WhiteHawk Income (NYSE:WHK) is now covered by Capital One Financial Corporation. They set an "overweight" rating and a $32.00 price target on the stock. This represents a 18.4% upside from the current price of $27.02. |
| WhiteHawk Income (NYSE:WHK) is now covered by Stifel Nicolaus. They set a "buy" rating and a $30.00 price target on the stock. This represents a 11.0% upside from the current price of $27.02. |
| WhiteHawk Income (NYSE:WHK) is now covered by JPMorgan Chase & Co.. They set a "neutral" rating and a $28.00 price target on the stock. This represents a 3.6% upside from the current price of $27.02. |
| Wise Group (NASDAQ:WSE) is now covered by JPMorgan Chase & Co.. They set an "overweight" rating and a $17.50 price target on the stock. This represents a 33.8% upside from the current price of $13.08. |